MicroRNA Editing Facilitates Immune Elimination of HCMV Infected Cells

PLoS Pathogens

Volumn 10, Issue 2, 2014, Pages

  Nachmani, Daphna ^a   Zimmermann, Albert ^b   Oiknine Djian, Esther ^a   Weisblum, Yiska ^a   Livneh, Yoav ^c   Khanh Le, Vu Thuy ^d   Galun, Eithan ^e   Horejsi, Vaclav ^f   Isakov, Ofer ^g   Shomron, Noam ^g   Wolf, Dana G ^a   Hengel, Hartmut ^b   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY   (Israel)

^b UNIVERSITY OF FREIBURG   (Germany)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^f INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^g TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADAR1 PROTEIN; ADAR2 PROTEIN; ADENOSINE DEAMINASE; HLA E ANTIGEN; MICRORNA; MIRNA 376A; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CELL ACTIVITY; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; CYTOTOXICITY ASSAY; FEMALE; FLOW CYTOMETRY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE TEST; IMMUNOMODULATION; LUCIFERASE ASSAY; NATURAL KILLER CELL; PATHOGEN CLEARANCE; PROMOTER REGION; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EDITING; RNA EXTRACTION; RNA SEQUENCE; WESTERN BLOTTING;

ADENOSINE DEAMINASE; BLOTTING, WESTERN; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; KILLER CELLS, NATURAL; MICRORNAS; RNA EDITING;

EID: 84895742059     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003963     Document Type: Article

References (52)

1. Mocarski ES Jr, (2002) Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol 10: 332-339.
2. Wilkinson GW, Tomasec P, Stanton RJ, Armstrong M, Prod'homme V, et al. (2008) Modulation of natural killer cells by human cytomegalovirus. J Clin Virol 41: 206-212.
3. Park B, Spooner E, Houser BL, Strominger JL, Ploegh HL, (2010) The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation. J Exp Med 207: 2033-2041.
4. Furman MH, Dey N, Tortorella D, Ploegh HL, (2002) The human cytomegalovirus US10 gene product delays trafficking of major histocompatibility complex class I molecules. J Virol 76: 11753-11756.
5. Tomasec P, Braud VM, Rickards C, Powell MB, McSharry BP, et al. (2000) Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287: 1031.
6. Ulbrecht M, Martinozzi S, Grzeschik M, Hengel H, Ellwart JW, et al. (2000) Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J Immunol 164: 5019-5022.
7. Arnon TI, Markel G, Mandelboim O, (2006) Tumor and viral recognition by natural killer cells receptors. Semin Cancer Biol 16: 348-358.
8. Long EO, Sik Kim H, Liu D, Peterson ME, Rajagopalan S, (2013) Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol 31: 227-258.
9. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, et al. (2001) Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19: 197-223.
10. Seidel E, Glasner A, Mandelboim O, (2012) Virus-mediated inhibition of natural cytotoxicity receptor recognition. Cell Mol Life Sci [epub ahead of print].
11. Ljunggren HG, Karre K, (1985) Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J Exp Med 162: 1745-1759.
12. Raulet DH, (2006) Missing self recognition and self tolerance of natural killer (NK) cells. Semin Immunol 18: 145-150.
13. O'Callaghan CA, (2000) Molecular basis of human natural killer cell recognition of HLA-E (human leucocyte antigen-E) and its relevance to clearance of pathogen-infected and tumour cells. Clin Sci (Lond) 99: 9-17.
14. O'Callaghan CA, (2000) Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors. Microbes Infect 2: 371-380.
15. Braud VM, Allan DS, O'Callaghan CA, Soderstrom K, D'Andrea A, et al. (1998) HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391: 795-799.
16. Guma M, Angulo A, Vilches C, Gomez-Lozano N, Malats N, et al. (2004) Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 104: 3664-3671.
17. Raulet DH, Gasser S, Gowen BG, Deng W, Jung H, (2013) Regulation of ligands for the NKG2D activating receptor. Annu Rev Immunol 31: 413-441.
18. Raulet DH, (2003) Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3: 781-790.
19. Nachmani D, Lankry D, Wolf DG, Mandelboim O, (2010) The human cytomegalovirus microRNA miR-UL112 acts synergistically with a cellular microRNA to escape immune elimination. Nat Immunol 11: 806-813.
20. Stern-Ginossar N, Gur C, Biton M, Horwitz E, Elboim M, et al. (2008) Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nat Immunol 9: 1065-1073.
21. Tsukerman P, Stern-Ginossar N, Gur C, Glasner A, Nachmani D, et al. (2012) MiR-10b downregulates the stress-induced cell surface molecule MICB, a critical ligand for cancer cell recognition by natural killer cells. Cancer Res 72: 5463-5472.
22. Kawahara Y, Zinshteyn B, Sethupathy P, Iizasa H, Hatzigeorgiou AG, et al. (2007) Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science 315: 1137-1140.
23. Farajollahi S, Maas S, (2010) Molecular diversity through RNA editing: a balancing act. Trends Genet 26: 221-230.
24. Nishikura K, (2010) Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem 79: 321-349.
25. Patterson JB, Samuel CE, (1995) Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol Cell Biol 15: 5376-5388.
26. George CX, Samuel CE, (1999) Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible. Proc Natl Acad Sci U S A 96: 4621-4626.
27. George CX, Samuel CE, (1999) Characterization of the 5′-flanking region of the human RNA-specific adenosine deaminase ADAR1 gene and identification of an interferon-inducible ADAR1 promoter. Gene 229: 203-213.
28. Kawakubo K, Samuel CE, (2000) Human RNA-specific adenosine deaminase (ADAR1) gene specifies transcripts that initiate from a constitutively active alternative promoter. Gene 258: 165-172.
29. Hartner JC, Schmittwolf C, Kispert A, Muller AM, Higuchi M, et al. (2004) Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J Biol Chem 279: 4894-4902.
30. Wang Q, Miyakoda M, Yang W, Khillan J, Stachura DL, et al. (2004) Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J Biol Chem 279: 4952-4961.
31. XuFeng R, Boyer MJ, Shen H, Li Y, Yu H, et al. (2009) ADAR1 is required for hematopoietic progenitor cell survival via RNA editing. Proc Natl Acad Sci U S A 106: 17763-17768.
32. Higuchi M, Maas S, Single FN, Hartner J, Rozov A, et al. (2000) Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 406: 78-81.
33. Samuel CE, (2012) ADARs: viruses and innate immunity. Curr Top Microbiol Immunol 353: 163-195.
34. Tenoever BR, Ng SL, Chua MA, McWhirter SM, Garcia-Sastre A, et al. (2007) Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 315: 1274-1278.
35. Taylor DR, Puig M, Darnell ME, Mihalik K, Feinstone SM, (2005) New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1. J Virol 79: 6291-6298.
36. Suspene R, Renard M, Henry M, Guetard D, Puyraimond-Zemmour D, et al. (2008) Inversing the natural hydrogen bonding rule to selectively amplify GC-rich ADAR-edited RNAs. Nucleic Acids Res 36: e72.
37. Chambers P, Rima BK, Duprex WP, (2009) Molecular differences between two Jeryl Lynn mumps virus vaccine component strains, JL5 and JL2. J Gen Virol 90: 2973-2981.
38. Bauman Y, Nachmani D, Vitenshtein A, Tsukerman P, Drayman N, et al. (2011) An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. Cell Host Microbe 9: 93-102.
39. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
40. Ebert MS, Neilson JR, Sharp PA, (2007) MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4: 721-726.
41. Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG, (1998) Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med 187: 813-818.
42. Houchins JP, Lanier LL, Niemi EC, Phillips JH, Ryan JC, (1997) Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J Immunol 158: 3603-3609.
43. Lee N, Llano M, Carretero M, Ishitani A, Navarro F, et al. (1998) HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci U S A 95: 5199-5204.
44. Weisblum Y, Panet A, Zakay-Rones Z, Haimov-Kochman R, Goldman-Wohl D, et al. (2011) Modeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ culture. J Virol 85: 13204-13213.
45. Skalsky RL, Cullen BR, (2010) Viruses, microRNAs, and host interactions. Annu Rev Microbiol 64: 123-141.
46. Li T, Chen J, Cristea IM, (2013) Human Cytomegalovirus Tegument Protein pUL83 Inhibits IFI16-Mediated DNA Sensing for Immune Evasion. Cell Host Microbe 14: 591-599.
47. Beziat V, Hervier B, Achour A, Boutolleau D, Marfain-Koka A, et al. (2011) Human NKG2A overrides NKG2C effector functions to prevent autoreactivity of NK cells. Blood 117: 4394-4396.
48. Magri G, Muntasell A, Romo N, Saez-Borderias A, Pende D, et al. (2011) NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 117: 848-856.
49. Bjorkstrom NK, Lindgren T, Stoltz M, Fauriat C, Braun M, et al. (2011) Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med 208: 13-21.
50. Stern-Ginossar N, Elefant N, Zimmermann A, Wolf DG, Saleh N, et al. (2007) Host immune system gene targeting by a viral miRNA. Science 317: 376-381.
51. Kozomara A, Griffiths-Jones S, (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39: D152-157.
52. Li H, Durbin R, (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754-1760.